Louisiana State Employees Retirement System Boosts Position in Becton, Dickinson and Company (NYSE:BDX)

Louisiana State Employees Retirement System increased its position in Becton, Dickinson and Company (NYSE:BDX) by 7.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,100 shares of the medical instruments supplier’s stock after buying an additional 1,000 shares during the period. Louisiana State Employees Retirement System’s holdings in Becton, Dickinson and were worth $2,751,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Crow Point Partners LLC increased its stake in Becton, Dickinson and by 263.6% in the second quarter. Crow Point Partners LLC now owns 4,868 shares of the medical instruments supplier’s stock valued at $941,000 after buying an additional 3,529 shares in the last quarter. Sky Investment Group LLC increased its stake in shares of Becton, Dickinson and by 2.1% in the second quarter. Sky Investment Group LLC now owns 26,742 shares of the medical instruments supplier’s stock valued at $5,218,000 after buying an additional 562 shares during the period. Ronna Sue Cohen increased its stake in shares of Becton, Dickinson and by 0.3% in the second quarter. Ronna Sue Cohen now owns 23,842 shares of the medical instruments supplier’s stock valued at $4,652,000 after buying an additional 80 shares during the period. Reinhart Partners Inc. increased its stake in shares of Becton, Dickinson and by 1.1% in the second quarter. Reinhart Partners Inc. now owns 1,986 shares of the medical instruments supplier’s stock valued at $387,000 after buying an additional 21 shares during the period. Finally, Winslow Evans & Crocker Inc. increased its stake in shares of Becton, Dickinson and by 17.7% in the second quarter. Winslow Evans & Crocker Inc. now owns 1,815 shares of the medical instruments supplier’s stock valued at $352,000 after buying an additional 273 shares during the period. 75.57% of the stock is currently owned by hedge funds and other institutional investors.

Becton, Dickinson and Company (BDX) traded down 0.81% during trading on Friday, reaching $197.69. The company had a trading volume of 989,225 shares. The firm’s 50 day moving average is $199.72 and its 200 day moving average is $188.69. The company has a market capitalization of $44.99 billion, a PE ratio of 57.25 and a beta of 1.05. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $206.63.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm had revenue of $3.04 billion during the quarter, compared to analysts’ expectations of $3.06 billion. During the same period in the previous year, the company earned $2.35 earnings per share. Becton, Dickinson and’s quarterly revenue was down 5.1% compared to the same quarter last year. On average, equities research analysts predict that Becton, Dickinson and Company will post $9.46 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be issued a $0.73 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.48%. Becton, Dickinson and’s payout ratio is 83.43%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2017/08/19/becton-dickinson-and-company-nysebdx-position-raised-by-louisiana-state-employees-retirement-system-updated-updated-updated.html.

A number of brokerages have issued reports on BDX. Barclays PLC restated an “equal weight” rating and issued a $210.00 price objective (up previously from $205.00) on shares of Becton, Dickinson and in a research note on Thursday, August 10th. BidaskClub cut Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research cut Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Thursday, May 4th. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Evercore ISI raised Becton, Dickinson and from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $186.00 to $200.00 in a report on Monday, April 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Becton, Dickinson and presently has a consensus rating of “Buy” and an average price target of $195.79.

In other news, insider Nabil Shabshab sold 6,149 shares of the business’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $201.76, for a total transaction of $1,240,622.24. Following the transaction, the insider now directly owns 15,648 shares in the company, valued at $3,157,140.48. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Jeffrey S. Sherman sold 28,765 shares of the business’s stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the transaction, the vice president now owns 70,821 shares in the company, valued at $13,171,289.58. The disclosure for this sale can be found here. Insiders sold 57,631 shares of company stock valued at $11,112,178 over the last ninety days. Corporate insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

What are top analysts saying about Becton Dickinson and Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Becton Dickinson and Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit